type here...

Capture

Antitrust and Competition

The Rise of the Opioids: How Purdue Invented New Markets for OxyContin

David Egilman, Gregory Collins, Julie Falender, Naomi Shembo, Ciara Keegan, Sunil Tohan
Purdue's strategy was to market its opioids directly to patients via brochures, videos, advertisements, and the internet. It also provided information to doctors and...
Regulatory Capture

Who Benefits When State Governments Award Incentives to Politically-Connected Companies?

Allison Koester
A new study finds that a company is nearly four times more likely to receive an economic incentive in a state where the company...
Academic Capture

Purdue Circumvented the Regulator to Promote OxyContin, Hiding Its Real Risk of Addiction

David Egilman, Gregory Collins, Julie Falender, Naomi Shembo, Ciara Keegan, Sunil Tohan
In 2001, the Food and Drug Administration required Purdue to change OxyContin’s patient package inserts to make addiction risks more evident. The company altered...
Academic Capture

“The Question Is Whether We Live in a Democracy or a Corporate State”

Asher Schechter
In an interview with ProMarket, Goliath author Matt Stoller discusses the political choices that led to the downfall of the American antimonopoly movement and the “addiction to...
Antitrust and Competition

"You Can Put the Monopoly Tiger in a Cage but You Cannot Transform a Tiger Into a Vegan"

Christoph Gisiger
In an extensive interview with the Swiss news website TheMarket.ch, Luigi Zingales discusses ways to deal with Big Tech and the impact of the...
Antitrust and Competition

Thomas Piketty, Chile's Political Chaos, and How to Change Capitalism for the Better: ProMarket’s Top Stories of 2019

ProMarket writers
As 2019 draws to a close, we look back at ProMarket’s most-read and most-widely shared stories of the past year.       Thomas Piketty’s long-anticipated follow-up to...
Academic Capture

The Best Political Economy Books of 2019

Asher Schechter
A history of American antimonopoly, the case against Big Tech, and how Europe got better than the US at free markets: here are (in no...
Academic Capture

OxyContin's Academic Marketing: The Studies That Fueled the Opioid Crisis

David Egilman, Gregory Collins, Julie Falender, Naomi Shembo, Ciara Keegan, Sunil Tohan
Purdue Pharmaceuticals used to cite three major studies to argue that in prescribing OxyContin, addiction-risk was not significant. The most influential of those studies...
Academic Capture

Western Multinationals Can Improve Workers' Safety, If They Want to: The Case of Bangladesh

Stefano Feltri
In 2013, one of the largest factories in Bangladesh collapsed, killing 1,134 workers. Many multinationals committed to improving safety standards. A new study shows...
ESG, Corporate Governance & Future of the Firm

Shareholders at the Gate: The Increasing Pressure on CEOs for More Transparency

Joost Sijthoff
The average share of votes in favor of proposals that require corporate executives to disclose political and lobbying spending is trending up. But a...
1...232425...46Page 24 of 46

Latest news

View All

The publication of the Stigler Center at The University of Chicago Booth School of Business

ProMarket is dedicated to discussing how competition tends to be subverted by special interests. The posts represent the opinions of their writers, not necessarily those of the University of Chicago, the Booth School of Business, or its faculty. For more information, please visit ProMarket Policy.